64 negative significant genes in sham-treated ME16C cells

7 positive significant genes in sham-treated ME16C cells

81 positive significant genes in sham-treated HME-CC cells

Supplemental Table I.  Differential expression of 162 genes based on Affymetrix GeneChip analysis.

Table 3 Differential expression of 24 genes based on the ABI microfluidic card

Supplementary Table 2: Changes in gene expression at day 5 of differentiation compared to day 4: down-regulation

Supplementary Table 1: Changes in gene expression at day 5 of differentiation compared to day 4: up-regulation

Supplementary Table 3: Changes in gene expression over the time course of differentiation compared to timecorresponding controls: up-regulation

cell differentiation markers : Human leukocyte and stromal cell molecules: the CD markers

Table 2. Genes differentially expressed in serous  Sertoli Leydig  and endometrioid ovarian tumors in comparison with normal ovarian tissue. Expression values for genes identified as significantly up- or downregulated in single comparison of serous tumors

Supplementary Table 1. list of 907 genes representing Sertoli Leydig ovarian tumor signature

Table 1. Differential gene expression in cord blood CD34+ cells expressing NUP98-HOXA9 relative to CD34+ cells transduced with the MIGR1 control vector

Table 1. Cell signaling pathways prominently altered in MCF7-T and MCF7-F

Table 2. Genes with altered expression and promoter methylation in MCF7-T and MCF7-F cells

Table 1a. Genes up-regulated by LGD1069 at 24 hours in HMECs

Table 1b. Genes down-regulated by LGD1069 at 24 hours in HMECs

Table S1b. List of differentially expressed clones between stroma microdissected from PIN (10-weeks old) and invasive-prostate cancers (24-weeks old) of CR2-TAg mice (FDR 15%).

Table S1a. List of differentially expressed clones between stroma microdissected from PIN (10-weeks old) and invasive-prostate cancers (24-weeks old) of CR2-TAg mice (FDR 15%).

Table 1. List of top 20 highly expressed genes encoding CD antigens generated by comparing gene expression profiles of E-RoSH and RoSH cells with E14 ESCs.